← Back to all trials
Recruiting
NCT05690451
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
Conditions: Hepatocellular Carcinoma
Sex: All
Ages: 20 Years – 85 Years
Enrollment: 210
Sponsor: Seoul National University Hospital
Location: Korea, Republic of
Summary
This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.
Eligibility Criteria
Inclusion Criteria:Age between 20-year old and 85-year oldPatients with a history of curative treatment for HCC including surgical resection or local ablationNo recurrence after curative treatment of HCC for more than two yearsPatient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)Exclusion Criteria:Estimated GFR less than 60Previous history of severe allergic reaction to the iodinated contrast agentPatients with claustrophobia who can't undergo MR examinationPatients having cochlear implants or cardiac pacemaker
Source: ClinicalTrials.gov (NCT05690451). StuddyBuddy aggregates publicly available trial information.